ウィルソン病治療薬の世界市場2019-2023...市場調査レポートについてご紹介

【英文タイトル】Global Wilson's Disease Drugs Market 2019-2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Chelators – Market size and forecast 2018-2023
• Minerals – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bausch Health Companies
• Mylan
• Recordati
• Teva Pharmaceutical Industries
• TSUMURA
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO


Exhibit 01:Global rare disease drugs market
Exhibit 02:Segments of global rare disease drugs market
Exhibit 03:Market characteristics
Exhibit 04:Market segments
Exhibit 05:Inheritance of Wilson’s disease
Exhibit 06:Market definition – Inclusions and exclusions checklist
Exhibit 07:Market size 2018
Exhibit 08:Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09:Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10:Five forces analysis 2018
Exhibit 11:Five forces analysis 2023
Exhibit 12:Bargaining power of buyers
Exhibit 13:Bargaining power of suppliers
Exhibit 14:Threat of new entrants
Exhibit 15:Threat of substitutes
Exhibit 16:Threat of rivalry
Exhibit 17:Market condition – Five forces 2018
Exhibit 18:Product – Market share 2018-2023 (%)
Exhibit 19:Comparison by product
Exhibit 20:Chelators: Mechanism of action
Exhibit 21:Chelators – Market size and forecast 2018-2023 ($ millions)
Exhibit 22:Chelators – Year-over-year growth 2019-2023 (%)
Exhibit 23:Minerals – Market size and forecast 2018-2023 ($ millions)
Exhibit 24:Minerals – Year-over-year growth 2019-2023 (%)
Exhibit 25:Market opportunity by product
Exhibit 26:Customer landscape
Exhibit 27:Market share by geography 2018-2023 (%)
Exhibit 28:Geographic comparison
Exhibit 29:Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 30:Americas – Year-over-year growth 2019-2023 (%)
Exhibit 31:Top 3 countries in Americas
Exhibit 32:EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 33:EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 34:Top 3 countries in EMEA
Exhibit 35:Country_Legend_2
Exhibit 36:APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 37:APAC – Year-over-year growth 2019-2023 (%)
Exhibit 38:Top 3 countries in APAC
Exhibit 39:Country_Legend_3
Exhibit 40:Key leading countries
Exhibit 41:Country_Legend_16
Exhibit 42:Market opportunity
Exhibit 43:Impact of drivers and challenges
Exhibit 45:Impact of drivers and challenges
Exhibit 46:Vendor landscape
Exhibit 47:Landscape disruption
Exhibit 48:Vendors covered
Exhibit 49:Vendor_analysis
Exhibit 50:Vendor classification
Exhibit 51:Market positioning of vendors
Exhibit 52:Bausch Health Companies – Vendor overview
Exhibit 53:Bausch Health Companies – Business segments
Exhibit 54:Bausch Health Companies – Organizational developments
Exhibit 55:Bausch Health Companies – Geographic focus
Exhibit 56:Bausch Health Companies – Segment focus
Exhibit 57:Bausch Health Companies – Key offerings
Exhibit 58:Bausch Health Companies – Key customers
Exhibit 59:Mylan – Vendor overview
Exhibit 60:Mylan – Business segments
Exhibit 61:Mylan – Organizational developments
Exhibit 62:Mylan – Geographic focus
Exhibit 63:Mylan – Key offerings
Exhibit 64:Mylan – Key customers
Exhibit 65:Recordati – Vendor overview
Exhibit 66:Recordati – Business segments
Exhibit 67:Recordati – Organizational developments
Exhibit 68:Recordati – Geographic focus
Exhibit 69:Recordati – Segment focus
Exhibit 70:Recordati – Key offerings
Exhibit 71:Recordati – Key customers
Exhibit 72:Teva Pharmaceutical Industries – Vendor overview
Exhibit 73:Teva Pharmaceutical Industries – Business segments
Exhibit 74:Teva Pharmaceutical Industries – Organizational developments
Exhibit 75:Teva Pharmaceutical Industries – Geographic focus
Exhibit 76:Teva Pharmaceutical Industries – Segment focus
Exhibit 77:Teva Pharmaceutical Industries – Key offerings
Exhibit 78:Teva Pharmaceutical Industries – Key customers
Exhibit 79:TSUMURA – Vendor overview
Exhibit 80:TSUMURA – Business segments
Exhibit 81:TSUMURA – Organizational developments
Exhibit 82:TSUMURA – Key offerings
Exhibit 83:TSUMURA – Key customers
Exhibit 84:Research framework
Exhibit 85:Validation techniques employed for market sizing
Exhibit 86:Information sources
Exhibit 87:List of abbreviations


【レポート販売概要】

■ タイトル:ウィルソン病治療薬の世界市場2019-2023
■ 英文:Global Wilson's Disease Drugs Market 2019-2023
■ 発行日:2018年11月22日
■ 調査会社:Technavio
■ 商品コード:IRTNTR30238
■ 調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。